Childhood Neuromuscular Disease as a Metaphor for the Scientific Advances in Child Neurology of the Last Quarter Century
John B. Bodensteiner, MD
Dr. Bodensteiner is Director of the American Board of Psychiatry and...
It is estimated that national screening will avert 33 annual deaths and 48 annual cases of ventilator dependence.
LOS ANGELES – Could results help to guide decisions on immunosuppressive treatment?
Dr. Sanjak describes a proposed test for assessing lower-limb muscle strength in patients with ALS.
LOS ANGELES – Members of the AAN Neurology Drug Pricing Task Force spoke about the issues that arise in getting patients access to high-cost drugs...
Hizentra is the first FDA-approved subcutaneously administered human immunoglobulin maintenance therapy for CIDP.
LAS VEGAS – As part of an open approach, educate patients about effective alternative treatments to medical cannabis, an expert advises.
A person with a spinal cord injury can improve his or her ability to grip and move household objects by using an electrical stimulation device...
From the Journals
The phase 1-2a study shows potential for mogamulizumab in the treatment of HAM-TSP.
Patients with spastic arm paralysis who receive a contralateral C7 nerve graft from their nonparalyzed side to their paralyzed side may have...
SAN DIEGO—Cross-species genetic screens are helping researchers find molecules that modulate the proteins that cause adult neurodegenerative...